Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 stockton street
San Francisco, CA 94133Phone+1 415-391-9686
Education & Training
Kern Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
CA State Medical License 1997 - 2026
NY State Medical License 2004 - 2013
PA State Medical License 2000 - 2004- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 26 citationsT-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.Iryna Zubkova, Y.H. Choi, Esther H. Chang, Kathleen F. Pirollo, T. Uren
Vaccine. 2009-04-28 - 74 citationsA Tumor-targeting p53 Nanodelivery System Limits Chemoresistance to Temozolomide Prolonging Survival in a Mouse Model of Glioblastoma MultiformeSang-Soo Kim, Antonina Rait, Eric Kim, Kathleen F. Pirollo, Esther H. Chang
Nanomedicine. 2015-02-01 - 73 citationsEncapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.Sang-Soo Kim, Antonina Rait, Eric Kim, James DeMarco, Kathleen F. Pirollo
Cancer Letters. 2015-12-01
Grant Support
- Nanoimmunoliposome-Complexed Spio: Tumor-Specific Detection Of Early Lung CancerNational Cancer Institute2008–2010
- A Tumor-Specific Nanoimmunocomplex Markedly Improves MR ImagingNational Cancer Institute2006
- A Dual Molecular/Tumor Targeting Therapy For PancaNational Cancer Institute2004–2005
- Enhancement Of Tumor-Targeted Transgene ExpressionNational Cancer Institute2004
- A Dual Molecular/Targeting Therapy For PancaNational Cancer Institute2003
- Immunoliposome-Mediated Gene Therapy For Prostate CancerNational Cancer Institute2002–2003
- Targeting Stealth Liposome For Cancer Gene TherapyNational Cancer Institute2002
- A Novel Improvement On Radiotherapy For ScchnNational Institute Of Dental &Craniofacial Research1999–2002
- Immunoliposome Mediated Gene Therapy For Prostate CancerNational Cancer Institute1999
- Status Of P53 In A Lfs Cancer Prone FamilyNational Cancer Institute1997–1999
- Status Of P53 In A Lfs Cancer Prone FamilyNational Cancer Institute1995–1996
- Oncogenes In Human Cancer InductionNational Cancer Institute1994
- Oncogenes In Human Cancer InductionNational Cancer Institute1986–1994
- Small Instrumentation ProgramNational Institute Of Allergy And Infectious Diseases1988
- Oncogenes (C-Ras) In Human Cancer InductionNational Cancer Institute1985
Other Languages
- Chinese (Mandarin), Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
